FASEX
Price
$53.09
Change
+$0.71 (+1.36%)
Updated
Apr 2 closing price
Net Assets
389.5M
VMVAX
Price
$83.95
Change
+$0.71 (+0.85%)
Updated
Apr 2 closing price
Net Assets
30.85B
Ad is loading...

FASEX vs VMVAX

Header iconFASEX vs VMVAX Comparison
Open Charts FASEX vs VMVAXBanner chart's image
Nuveen Mid Cap Value 1 A
Price$53.09
Change+$0.71 (+1.36%)
VolumeN/A
Net Assets389.5M
Vanguard Mid-Cap Value Index Admiral
Price$83.95
Change+$0.71 (+0.85%)
VolumeN/A
Net Assets30.85B
FASEX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FASEX vs. VMVAX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FASEX is a Buy and VMVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.8B vs. FASEX (390M). VMVAX pays higher dividends than FASEX: VMVAX (2.33) vs FASEX (0.96). FASEX was incepted earlier than VMVAX: FASEX (37 years) vs VMVAX (14 years). FASEX (1.22) is less costly to investors than VMVAX (0.07). VMVAX is a more actively managed with annual turnover of: 22.00 vs. FASEX (20.00). FASEX has a lower initial minimum investment than VMVAX: FASEX (2500) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 4.97 vs. FASEX (-3.80). VMVAX return over 5 years is better than : 114.64 vs. FASEX (103.57).
FASEXVMVAXFASEX / VMVAX
Total Expense Ratio1.130.071,614%
Annual Report Gross Expense Ratio1.220.071,743%
Fund Existence37 years14 years-
Gain YTD-3.554-0.596596%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets390M30.8B1%
Annual Yield % from dividends0.962.3341%
Returns for 1 year-3.804.97-76%
Returns for 3 years-2.517.78-32%
Returns for 5 years103.57114.6490%
Returns for 10 years51.9178.2366%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEYCX30.31N/A
N/A
American Century Equity Growth C
KTRCX8.75N/A
N/A
DWS Global Income Builder C
VADFX72.63N/A
N/A
Invesco Equally-Wtd S&P 500 R6
CLTCX14.19N/A
N/A
Catalyst/Lyons Tactical Allocation C
FIFPX21.33N/A
N/A
Fidelity Advisor Founders M